Last reviewed · How we verify
NCT07095777
Study on the Recovery of Visual Perceptual Function Dysfunction in Patients With Diabetes
NA trial testing visual perceptual learning in Diabetic Retinopathy (DR) in 36 participants. Completed in 9 August 2024.
31 July 2024
Quick facts
| Lead sponsor | The First Affiliated Hospital of Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 March 2023 |
| Primary completion | 31 July 2024 |
| Estimated completion | 9 August 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- visual perceptual learning
Conditions studied
- Diabetic Retinopathy (DR) — all drugs for Diabetic Retinopathy (DR) →
- Visual Perception — all drugs for Visual Perception →
Sponsor
The First Affiliated Hospital of Anhui Medical University
Who can join
Adults 18 to 65, any sex, with Diabetic Retinopathy (DR) or Visual Perception. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators aim to investigate the effectiveness of visual perceptual learning on visual perceptual function in participants with diabetic retinopathy and to provide novel therapeutic insights for visual functional rehabilitation in diabetic retinopathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07095777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Retinopathy (DR)
Currently open trials in the same condition.
- NCT07378956 — Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus · NA · recruiting
- NCT07520045 — Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab · NA · recruiting
- NCT07296952 — Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRO · NA · recruiting
- NCT07468058 — Diabetic Retinopathy Prevalence And Risk Factors · recruiting
- NCT07069647 — Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in F · NA · recruiting
Other The First Affiliated Hospital of Anhui Medical University trials
Trials by the same sponsor.
- NCT07273890 — Real-time Feedback of Red-out Within Colonoscopy Intubation · NA · not yet recruiting
- NCT07346378 — Clinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia · NA · recruiting
- NCT07247682 — Dose-escalation of Rectal Indomethacin for Preventing PEP · Phase 4 · not yet recruiting
- NCT07194109 — Remiazolam vs Propofol Total Intravenous Anesthesia on Postoperative Neurodevelopment After General Anesthesia in Childr · Phase 4 · not yet recruiting
- NCT07086287 — Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07095777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Anhui Medical University
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07095777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing